EFFECT OF ADDITION OF SINGLE DOSE OF ORAL MONTELUKAST TO STANDARD THERAPY IN ACUTE MODERATE ASTHMA IN CHILDREN 5 to 12 YEARS OF AGE: A RANDOMISED DOUBLE-BLIND PLACEBO CONTROLLED TRIAL